Ashley H Williams

Ashley H Williams has extensive work experience in the pharmaceutical and clinical research industry. Ashley H currently holds the position of Head of Study Optimization at Daiichi Sankyo, Inc., where they are responsible for optimizing study processes and leading a team. Prior to this role, they served as the Sr. Director and Head of Trial Feasibility & Site ID at the same company, where they developed and launched a feasibility and site identification department. Ashley H also played a key role in advocating for and implementing new tools for departmental usage.

Before joining Daiichi Sankyo, Inc., Ashley worked at Biogen as an Associate Director. In this role, they led strategic initiatives related to portfolio governance, analytics, and clinical operations. Ashley H successfully launched a new governance body called the Technical Review Committee and managed a committee comprised of senior R&D leaders. Ashley H also led process improvement and technology deployment projects in the Global Clinical Operations team.

Prior to their work at Biogen, Ashley held positions at PAREXEL as a Senior Feasibility Specialist and at Bristol-Myers Squibb as a Clinical Trials Associate. Ashley H began their career at Yale School of Medicine as a Senior Clinical Research Coordinator.

Overall, Ashley H Williams has a strong background in clinical research operations, feasibility, site identification, and portfolio governance. Ashley H has demonstrated leadership skills and a track record of successfully implementing new initiatives in the pharmaceutical industry.

Ashley H Williams obtained a Bachelor's Degree in Experimental Psychology from Fairfield University in 2009. Ashley H also holds a certification in Green Belt Lean Six Sigma, but information about the institution, month of obtaining, and year of obtaining is unavailable.